Cover Image
市場調查報告書

全球獸醫醫療市場:成長,趨勢,預測

Global Veterinary Healthcare Market - Growth, Trends and Forecast (2016 - 2021)

出版商 Mordor Intelligence LLP 商品編碼 319379
出版日期 內容資訊 英文 211 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球獸醫醫療市場:成長,趨勢,預測 Global Veterinary Healthcare Market - Growth, Trends and Forecast (2016 - 2021)
出版日期: 2016年08月01日 內容資訊: 英文 211 Pages
簡介

全球獸醫醫療市場在2014年為248億美元規模。該市場預測到2019前將以年複合成長率7.86%的速度擴大,世界性需求預測在2019年前將達到343億9,000萬美元的規模。

本報告提供全球獸醫醫療市場現況與未來預測,提供您各市場區隔,各地區趨勢,並彙整主要的參與企業競爭環境與簡介等資料。

第1章 簡介

第2章 市場分析

  • 動物醫療產品
  • 價值鏈分析
  • 動物醫療和人的醫療

第3章 市場趨勢

  • 推動市場的要素
    • 寵物飼主感情
    • 營養的改善
    • 消費者對食品安全性的注意力提升
    • 飼料的增產
    • 動物平原性傳染病及透過食物傳染的疾病
  • 阻礙市場的要素
    • 耕地和水的危機
    • 耕地的競爭激烈
    • 成本效益高的生產
  • 波特五力分析

第4章 市場區隔:全球動物醫療

  • 市場區隔:動物為基礎的產品種類
  • 動物診斷藥
  • 基因研究
  • 類別市場區隔
  • 各地區市場市場區隔
    • 亞太地區
    • 歐洲
    • 北美
    • 南美

第5章 競爭環境

  • 市場上主要企業
  • 市場佔有率分析
  • 合併·收購
  • 新產品上市
  • 協定,聯合,夥伴關係

第6章 市場上龍頭企業

  • Zoetis Animal Healthcare
  • Merck Ltd.
  • Merial ( Animal Health division of Sanofi)
  • Elanco Animal Health
  • Bayer Animal Health
  • Novartis Animal Health
  • Virbac Animal Health
  • Boehringer Ingelheim

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The global veterinary healthcare market, estimated at USD 25 billion in 2015, is set to reach USD 39.7 billion by 2021, with a CAGR of 8.06% over the forecast period of 2016 to 2021. The animal health market is a growing industry comprising companion animals and farm animals. Companion animals are those that people tame or adopt for companionship or as house/office guards and farm animals are the ones raised for meat, milk etc. Companion animals include dogs, cats, and horses. Farm animals are cattle, poultry, swine, etc.

Leading companies in the market are actively producing and manufacturing animal healthcare products, pharmaceuticals, and others. This market research report provides in-depth market intelligence on the animal healthcare industry.

Global Veterinary Healthcare Market- Market Dynamics

The importance of livestock animals is generating growth in the animal healthcare market. The population boom and the stable economy is expected to result in increased demand for protein-rich foods, especially in developing regions. Animal health companies are well positioned to address this growing emerging market demand for higher-protein diets.

The new types of diseases in animals and their subsequent transfer to humans via animal food product consumption and companionship are escalating the veterinary healthcare industry globally. The strategic decisions in research and development of manufacturers are expected to positively impact global veterinary healthcare market.

Drivers

Some of the key factors driving the market towards growth are:

  • Increased love for pets leading to increased ownership
  • Increasing awareness of zoonotic diseases
  • Fewer requirements for animal health drugs
  • Continuous innovations
  • Government initiatives worldwide on animal healthcare such as compulsory immunization policy for animals in China
  • Technological advances in development of animal health drugs

However, increased competition for cultivated land and scarcity of arable land are the major restraints of the market growth.

The market has been segmented based on products, pharmaceuticals, diagnostics, type of animals and geography.

  • Based on products, the market has been segmented into pharmaceuticals/ biopharmaceuticals and diagnostics.
  • Based on pharmaceuticals/ biopharmaceuticals, the market has been segmented into vaccines, parasiticides, anti-infectives, medicinal feed additives and other pharmaceuticals.
  • Based on diagnostics, the market has been segmented into immunodiagnostics, molecular diagnostics, diagnostic imaging, clinical chemistry and others.
  • Based on animal types, the market has been segmented into companion animals and farm animals. The companion animal includes dogs, cats, and horses. The farm animal market includes cattle, swine, sheep and poultry.
  • Geographically, the market is segmented into North America, Europe, Asia-Pacific, Latin America and ROW (Rest of world). North America has been further segmented into USA, Canada, and Mexico. The European market has been segmented into Germany, UK, France, Spain, Italy, Scandinavia, BENELUX and rest of Europe. The Asia-Pacific market has been segmented into Japan, China, India, South Korea, Australia, New Zealand and rest of Asia-Pacific.

Some of the key players in the market are:

  • Bayer Animal Health
  • Ceva Animal Healthcare
  • Elanco Animal Health
  • Merck Ltd.
  • Merial (Animal Health division of Sanofi)
  • Zoetis Animal Healthcare

Key Deliverables in the Study

  • Market analysis for the veterinary healthcare market, with region-specific assessments and competition analysis on the global and regional scale.
  • Market definition along with the identification of key drivers and restraints.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their market share.
  • Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
  • A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
  • Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Study Assumption
  • 1.3. Report Description

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Analysis Methodology
  • 2.3. Study timeline
  • 2.4. Study phases
    • 2.4.1. Secondary Research
    • 2.4.2. Discussion Guide
    • 2.4.3. Market Engineering &Econometric Modeling
    • 2.4.4. Expert Validation

3. Executive Summary

4. Key Inferences

5. Market Dynamics

  • 5.1. Market Drivers
    • 5.1.1. Increasing Pet ownership
    • 5.1.2. Increasing disease prevalence in animals
    • 5.1.3. Rising incidence of zoonotic & foodborne diseases
    • 5.1.4. Increasing government initiatives and animal welfare association initiatives in different countries
  • 5.2. Market Restraint
    • 5.2.1. Scarcity of arable land and water
    • 5.2.2. Increased competition for cultivated land
  • 5.3. Opportunities
  • 5.4. Challenges
  • 5.5. Porter's Five Force Analysis
    • 5.5.1. Threat of New Entrant
    • 5.5.2. Bargaining power of Buyer
    • 5.5.3. Bargaining power of Supplier
    • 5.5.4. Threat of Substitution
    • 5.5.5. Competitive rivalry

6. Market Segmentation

  • 6.1. By Animal type
    • 6.1.1. Farm Animals
      • 6.1.1.1. Poultry
      • 6.1.1.2. Swine
      • 6.1.1.3. Cattle
      • 6.1.1.4. Sheep
    • 6.1.2. Companion Animal
      • 6.1.2.1. Dogs & Cats
      • 6.1.2.2. Horse
  • 6.2. By type of product
    • 6.2.1. Pharmaceuticals & Bio-Pharmaceuticals
      • 6.2.1.1. Vaccines
      • 6.2.1.2. Parasiticides
      • 6.2.1.3. Anti-infective agents
      • 6.2.1.4. Medicinal feed additives
      • 6.2.1.5. Other Pharmaceuticals
    • 6.2.2. Animal Diagnostic tests
      • 6.2.2.1. Immunodiagnostic tests
      • 6.2.2.2. Molecular diagnostics
      • 6.2.2.3. Diagnostic Imaging
      • 6.2.2.4. Clinical chemistry & others

7. Global Veterinary healthcare market segmentation by Geography

  • 7.1. North America
    • 7.1.1. USA
    • 7.1.2. Canada
    • 7.1.3. Mexico
  • 7.2. Europe
    • 7.2.1. France
    • 7.2.2. Germany
    • 7.2.3. UK
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Scandinavia
    • 7.2.7. Benelux
    • 7.2.8. Rest of Europe
  • 7.3. Asia-Pacific
    • 7.3.1. China
    • 7.3.2. India
    • 7.3.3. Japan
    • 7.3.4. Australia & New Zealand
    • 7.3.5. Rest of Asia-Pacific
  • 7.4. Middle East & Africa
    • 7.4.1. GCC
    • 7.4.2. South Africa
    • 7.4.3. Rest of the Middle East & Africa
  • 7.5. South America
    • 7.5.1. Brazil
    • 7.5.2. Argentina
    • 7.5.3. Rest of South America

8. Competitive Landscape

  • 8.1. Mergers and acquisitions
  • 8.2. Agreement, collaborations, and partnerships
  • 8.3. New product launches

9. Key Vendor Analysis

  • 9.1. Zoetis Animal Healthcare
  • 9.2. Merck Ltd.
  • 9.3. Merial (Animal Health division of Sanofi)
  • 9.4. Elanco Animal health
  • 9.5. Bayer Animal Health
  • 9.6. Ceva Animal Healthcare
  • 9.7. Virbac Animal Healthcare
  • 9.8. Boehringer Ingelheim
  • 9.9. Abaxis
  • 9.10. IDVet

10. Analyst outlook on investment opportunities

11. Future outlook of the market

Back to Top